WeHand-Bio Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 4

WeHand-Bio General Information


Provider of drug research and development services intended to focus on the treatment of diabetic diseases. The company creates drugs used mainly for the treatment of diabetes, tumors and influenza, enabling the clients to receive patented drugs which can be used both in tablet and injection form.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • No. 30, Tianfu Street, Daxing Biomedical Industry Base
  • Zhongguancun Science Park
  • Beijing, 102600
  • China
+86 010 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

WeHand-Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 07-Sep-2015 Completed Generating Revenue
1. Early Stage VC 27-Nov-2014 Completed Generating Revenue
To view WeHand-Bio’s complete valuation and funding history, request access »

WeHand-Bio Executive Team (1)

Name Title Board Seat Contact Info
Yuesheng Huang Chairman & Founder
To view WeHand-Bio’s complete executive team members history, request access »

WeHand-Bio Board Members (1)

Name Representing Role Since
Yuesheng Huang WeHand-Bio Chairman & Founder 000 0000
To view WeHand-Bio’s complete board members history, request access »

WeHand-Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cowin Capital Venture Capital Minority 000 0000 000000 0
Lapam Capital Venture Capital Minority 000 0000 000000 0
Northern Light Venture Capital Venture Capital Minority 000 0000 000000 0
Lang Sheng Investment Venture Capital Minority 000 0000 000000 0
To view WeHand-Bio’s complete investors history, request access »